Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles

Journal of Orthopaedic Research

Volumn 29, Issue 7, 2011, Pages 984-992

  Hirayama, Tomoyuki ^a   Tamaki, Yasunobu ^a   Takakubo, Yuya ^a   Iwazaki, Kiyoshi ^a   Sasaki, Kan ^a   Ogino, Toshihiko ^a   Goodman, Stuart B ^b   Konttinen, Yrjö T ^c,d   Takagi, Michiaki ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

aseptic loosening; lipopolysaccharide; macrophages; Toll like receptor; total joint arthroplasty

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TITANIUM; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENDOPROSTHESIS LOOSENING; IMMUNE RESPONSE; MACROPHAGE FUNCTION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ARTHROPLASTY, REPLACEMENT; BONE MARROW CELLS; CELLS, CULTURED; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; MYELOID DIFFERENTIATION FACTOR 88; PHAGOCYTOSIS; PROSTHESIS FAILURE; RATS; RATS, WISTAR; TITANIUM; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 79955909043     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21369     Document Type: Article

References (45)

1. Goodman SB, Huie P, Song Y, et al. 1997. Loosening and osteolysis of cemented joint arthroplasties. A biologic spectrum. Clin Orthop Relat Res 337: 146-163.
2. Santavirta S, Konttinen YT, Bergroth V, et al. 1990. Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg Am 72: 252-258. (Pubitemid 20123696)
3. Bi Y, Seabold JM, Kaar SG, et al. 2001. Adherent endotosin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 16: 2082-2091. (Pubitemid 32995400)
4. Lee DH, Park JC, Suh H., 2001. Synergistic induction of cyclooxygenase-II by bacterial lipopolysaccharide in combination with particles of medical device materials in a murine macrophage cell line J774A.1. J Biomed Mater Res 55: 547-553. (Pubitemid 32336285)
5. Charlebois SJ, Daniels AU, Smith RA., 2002. Metabolic heat production as a measure of macrophage response to particle from orthopedic implant materials. J Biomed Mater Res 59: 166-175.
6. Skoglund B, Larsson L, Aspenberg PA., 2002. Bone-resorptive effects of endotoxin-contaminated high-density polyethylene particles spontaneously eliminated in vivo. J Bone Joint Surg Br 84: 767-773. (Pubitemid 34846396)
7. Taki N, Tatro JM, Nalepka JL, et al. 2005. Polyethylene and titanium particles induce osteolysis by similar, lymphocyte-independent, mechanisms. J Orthop Res 23: 376-383. (Pubitemid 40287864)
8. Tatro JM, Taki N, Islam AS, et al. 2007. The balance between endotoxin accumulation and clearance during particle-induced osteolysis in murine calvaria. J Orthop Res 25: 361-369. (Pubitemid 46455907)
9. Greenfield EM, Bi Y, Ragab AA, et al. 2005. Dose endotosin contribute to aseptic loosening of orthopedic implants ? J Biomed Mater Res B Appl Biomater 72: 179-185. (Pubitemid 40039625)
10. Smith MV, Lee MJ, Islam AS, et al. 2007. Inhibition of the PI3K-Akt signaling pathway reduces tumor necrosis factor-alpha production in response to titanium particles in vitro. J Bone Joint Surg Am 89: 1019-1027. (Pubitemid 46724592)
11. Takeda K, Akira S., 2004. TLR signaling pathways. Semin Immunol 16: 3-9. (Pubitemid 38147427)
12. Akira S, Uematsu S, Takeuchi O., 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
13. Kawai T, Akira S., 2007. TLR signaling. Semin Immunol 19: 24-32. (Pubitemid 46498752)
14. Friberger P., 1985. The design of a reliable endotoxin test. Prog Clin Biol Res 189: 139-149.
15. Goto T, Edén S, Nordenstam G, et al. 1994. Endotoxin levels in sera of elderly individuals. Clin Diagn Lab Immunol 6: 684-688. (Pubitemid 2164296)
16. Nádházi Z, Takáts A, Offenmüller K, et al. 2002. Plasma endotoxin level of healthy donors. Acta Microbiol Immunol Hung 49: 151-157. (Pubitemid 135704973)
17. Nalepka JL, Greenfield EM., 2004. Detection of bacterial endotoxin in human tissues. Biotechniques 37: 413-417. (Pubitemid 39180915)
18. Nalepka JL, Lee MJ, Kraay MJ, et al. 2006. Lipopolysaccharide found in aseptic loosening of patients with inflammatory arthritis. Clin Orthop Relat Res 451: 229-235. (Pubitemid 44511333)
19. Engesaeter LB, Lie SA, Espehaug B, et al. 2003. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 promary hip replacements followed 0-14 years in the Noregian Arthroplasty Register. Acta Orthop Scand 74: 644-651. (Pubitemid 38067862)
20. Bi Y, Collier TO, Goldberg VM, et al. 2002. Adherent endotoxin mediates biological responses of titanium particles without stimulating their phagocytosis. J Orthop Res 20: 696-703. (Pubitemid 34822988)
21. Takagi M, Tamaki Y, Hasegawa H, et al. 2007. Toll-like receptors in the interface membrane around loosening total hip replacement implants. J Biomed Mater Res A 81: 1017-1026. (Pubitemid 46835099)
22. Tamaki Y, Takakubo Y, Goto K, et al. 2009. Increased expression of toll-like receptors in aseptic loose periprosthetic tissue and septic synovial membranes around total hip implants. J Rheumatol 36: 598-608.
23. Tamaki Y, Sasaki K, Sasaki A, et al. 2008. Enhanced osteolytic potential of monocytes/macrophages derived from bone marrow after particle stimulation. J Biomed Mater Res B Appl Biomater 84: 191-204.
24. Ragab AA, Motter RVD, Lavish SA, et al. 1999. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 17: 803-809. (Pubitemid 30033279)
25. Sasaki K, Takagi M, Mandelin J, et al. 2001. Quantitative analysis of mRNA expression of TIMPs in the periprosthetic interface tissue of loose hips by real-time PCR system. J Biomed Mater Res 58: 605-612. (Pubitemid 33096559)
26. Sasaki K, Takagi M, Konttinen YT, et al. 2007. Upregulation of matrix metalloproteinase (MMP)-1 and its activator MMP-3 of human osteoblast by uniaxialcyclic stimulation. J Bioned Mater Res B Appl Biomater 80: 491-498.
27. Blaine TA, Rosier RN, Puzas JE, et al. 1996. Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Joint Surg Am 78: 1181-1192. (Pubitemid 26284892)
28. Akisue T, Bauer TW, Farver CF, et al. 2002. The effect of particle wear debris of NF kappa B activation and pro-inflammatory cytokine release in differentiated THP-1 cells. J Biomed Mater Res 59: 507-515. (Pubitemid 34037495)
29. Fong Y, Tracey KJ, Moldawer LL, et al. 1989. Antibodies to cachectin/tumor mecrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med 170: 1627-1633. (Pubitemid 19284562)
30. Zeisberger E, Roth J., 1998. Tolerance to pyrogens. Ann N Y Acad Sci 856: 116-131. (Pubitemid 28517344)
31. West MA, Heagy W., 2002. Endotoxin tolerance: a review. Crit Care Med 30: S64-S73. (Pubitemid 34131164)
32. De Nardo D, De Nardo CM, Nguyen T, et al. 2009. Signaling crosstalk during sequential TLR4 and TLR9 activation amplifiles the inflammatory response of mouse macrophages. J Immunol 183: 8110-8118.
33. Pan H, Ding E, Hu M, et al. 2010. SMAD4 is required for development of maximal endotoxin tolerance. J Immunol 184: 5502-5509.
34. De Nardo D, Nguyen T, Hamilton JA, et al. 2009. Down-regulation of IRAK-4 is a component of LPS- and CpG DNA-induced tolerance in macrophages. Cell Signal 21: 246-252.
35. Dobrovolskaia MA, Medvedev AE, Thomas KE, et al. 2003. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J Immunol 170: 508-519. (Pubitemid 36026178)
36. Jacinto R, Hartung T, McCall C, et al. 2002. Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J Immunol 168: 6136-6141. (Pubitemid 34620031)
37. Mizel SB, Snipes JA., 2002. Gram-negative flagellin-induced self-tolerance is associated with a block in interleukin-1 receptor-associated kinase release from toll-like receptor 5. J Biol Chem 277: 22414-22420. (Pubitemid 34967211)
38. Siedlar M, Frankenberger M, Benkhart E, et al. 2004. Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1. J Immunol 173: 2736-2745. (Pubitemid 39063135)
39. Yeo SJ, Yoon JG, Hong SC, et al. 2003. CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: alterations in IL-1 receptor-associated kinase expression. J Immunol 170: 1052-1061.
40. An H, Xu H, Yu Y, et al. 2002. Up-regulation of TLR 9 gene expression by LPS in mouse macrophages via activation of NF-κB, ERK and p38 MAPK signal pathways. Immunol Lett 81: 165-169. (Pubitemid 34310220)
41. Matsuguchi T, Musikacharoen T, Ogawa T, et al. 2000. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 165: 5767-5772.
42. Medvedev AE, Kopydlowski KM, Vogel SN., 2000. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 164: 5564-5574. (Pubitemid 30389795)
43. Liu Y, Wang Y, Yamakuchi M, et al. 2001. Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa b activation. Infect Immun 69: 2788-2796. (Pubitemid 32332166)
44. Muzio M, Ni J, Feng P, et al. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-signaling. Science 278: 1612-1615. (Pubitemid 27516277)
45. Chung JY, Park YC, Ye H, et al. 2002. All TRAFs are not created equal: common and distinct molecular mechanism of TRAF-mediated signal transduction. J Cell Sci 115: 679-688. (Pubitemid 34196328)